210 related articles for article (PubMed ID: 21262847)
1. Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling.
Jennings-Antipov LD; Song L; Collier RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1868-73. PubMed ID: 21262847
[TBL] [Abstract][Full Text] [Related]
2. A semisynthesis platform for investigating structure-function relationships in the N-terminal domain of the anthrax Lethal Factor.
Pentelute BL; Barker AP; Janowiak BE; Kent SB; Collier RJ
ACS Chem Biol; 2010 Apr; 5(4):359-64. PubMed ID: 20180595
[TBL] [Abstract][Full Text] [Related]
3. Membrane translocation by anthrax toxin.
Collier RJ
Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.
Melnyk RA; Hewitt KM; Lacy DB; Lin HC; Gessner CR; Li S; Woods VL; Collier RJ
J Biol Chem; 2006 Jan; 281(3):1630-5. PubMed ID: 16293620
[TBL] [Abstract][Full Text] [Related]
5. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
[TBL] [Abstract][Full Text] [Related]
6. A model of anthrax toxin lethal factor bound to protective antigen.
Lacy DB; Lin HC; Melnyk RA; Schueler-Furman O; Reither L; Cunningham K; Baker D; Collier RJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16409-14. PubMed ID: 16251269
[TBL] [Abstract][Full Text] [Related]
7. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
8. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM structure of the fully-loaded asymmetric anthrax lethal toxin in its heptameric pre-pore state.
Antoni C; Quentin D; Lang AE; Aktories K; Gatsogiannis C; Raunser S
PLoS Pathog; 2020 Aug; 16(8):e1008530. PubMed ID: 32810181
[TBL] [Abstract][Full Text] [Related]
10. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
11. Role of toxin functional domains in anthrax pathogenesis.
Brossier F; Weber-Levy M; Mock M; Sirard JC
Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
[TBL] [Abstract][Full Text] [Related]
12. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
Krantz BA; Finkelstein A; Collier RJ
J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
[TBL] [Abstract][Full Text] [Related]
13. Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins.
Basilio D; Jennings-Antipov LD; Jakes KS; Finkelstein A
J Gen Physiol; 2011 Apr; 137(4):343-56. PubMed ID: 21402886
[TBL] [Abstract][Full Text] [Related]
14. Site-Specific Labeling and
Gonti S; Westler WM; Miyagi M; Bann JG
Biochemistry; 2021 Mar; 60(9):643-647. PubMed ID: 33428379
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
16. Secondary Structure Preferences of the Anthrax Toxin Protective Antigen Translocase.
Das D; Krantz BA
J Mol Biol; 2017 Mar; 429(5):753-762. PubMed ID: 28115202
[TBL] [Abstract][Full Text] [Related]
17. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
Young JA; Collier RJ
Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.
Feld GK; Thoren KL; Kintzer AF; Sterling HJ; Tang II; Greenberg SG; Williams ER; Krantz BA
Nat Struct Mol Biol; 2010 Nov; 17(11):1383-90. PubMed ID: 21037566
[TBL] [Abstract][Full Text] [Related]
19. Polylysine-mediated translocation of the diphtheria toxin catalytic domain through the anthrax protective antigen pore.
Sharma O; Collier RJ
Biochemistry; 2014 Nov; 53(44):6934-40. PubMed ID: 25317832
[TBL] [Abstract][Full Text] [Related]
20. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
